Skip to main content
Erschienen in: Supportive Care in Cancer 10/2012

01.10.2012 | Original Article

Validation of the Chinese version of Multidimensional Fatigue Inventory-20 in Chinese patients with cancer

verfasst von: Jun Tian, Jin-Sheng Hong

Erschienen in: Supportive Care in Cancer | Ausgabe 10/2012

Einloggen, um Zugang zu erhalten

Abstract

Goals of work

The purpose of this research is to study the validation of the Chinese version of Multidimensional Fatigue Inventory-20 in measuring fatigue status of the patients with cancer in China.

Materials and methods

The original English version of the Multidimensional Fatigue Inventory-20 was translated into a Chinese version, which was applied to measure the fatigue status of cancer patients prior to commencing chemotherapy and during the last week of chemotherapy, respectively. The reliability and criterion-related validity of the Chinese version of the Multidimensional Fatigue Inventory-20 were assessed by calculating Cronbach's α and Pearson correlation coefficients. The construct validity was analyzed by employing factor analysis.

Main results

There were three dimensions in the Chinese version of the MFI-20, which measures the physical, mental, and spiritual fatigue of patients with cancer. All of the correlation coefficients between EORTC QLQ-C30V3.0 and MFI-20 were statistically significant (P < 0.0001). The Cronbach's α coefficient was more than 0.8 and 0.7 for total MFI-20 and for the three dimensions of the Chinese version of the MFI-20, respectively.

Conclusions

The Chinese version of the MFI-20 is a reliable and valid instrument to assess fatigue in Chinese patients with cancer.
Literatur
1.
Zurück zum Zitat Winningham ML, Nail LM, Burke MB et al (1994) Fatigue and the cancer experience: the state of the knowledge. Oncol Nurs Forum 21(1):23–36PubMed Winningham ML, Nail LM, Burke MB et al (1994) Fatigue and the cancer experience: the state of the knowledge. Oncol Nurs Forum 21(1):23–36PubMed
2.
Zurück zum Zitat Giacalone A, Polesel J, Paoli AD et al (2010) Assessing cancer-related fatigue: the psychometric properties of the Revised Piper Fatigue Scale in Italian cancer inpatients. Support Care Cancer 18:1191–1197PubMedCrossRef Giacalone A, Polesel J, Paoli AD et al (2010) Assessing cancer-related fatigue: the psychometric properties of the Revised Piper Fatigue Scale in Italian cancer inpatients. Support Care Cancer 18:1191–1197PubMedCrossRef
3.
Zurück zum Zitat Haghighat S, Akbari ME, Holakouei K et al (2003) Factors predicting fatigue in breast cancer patients. Support Care Cancer 11(8):533–538PubMedCrossRef Haghighat S, Akbari ME, Holakouei K et al (2003) Factors predicting fatigue in breast cancer patients. Support Care Cancer 11(8):533–538PubMedCrossRef
4.
Zurück zum Zitat Romito F, Montanaro R, Corvasce C et al (2008) Is cancer-related fatigue more strongly correlated to haematological or to psychological factors in cancer patients? Support Care Cancer 16(8):943–946PubMedCrossRef Romito F, Montanaro R, Corvasce C et al (2008) Is cancer-related fatigue more strongly correlated to haematological or to psychological factors in cancer patients? Support Care Cancer 16(8):943–946PubMedCrossRef
5.
Zurück zum Zitat Curt GA, Breitbart W et al (2000) Impact of cancerrelated fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist 5:353–360PubMedCrossRef Curt GA, Breitbart W et al (2000) Impact of cancerrelated fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist 5:353–360PubMedCrossRef
6.
Zurück zum Zitat Chang YJ, Lee JS, Lee CG et al (2007) Assessment of clinical relevant fatigue level in cancer. Support Care Cancer 15(7):891–896PubMedCrossRef Chang YJ, Lee JS, Lee CG et al (2007) Assessment of clinical relevant fatigue level in cancer. Support Care Cancer 15(7):891–896PubMedCrossRef
7.
Zurück zum Zitat Piper BF, Lindsey AM, Dodd MJ (1987) Fatigue mechanism in cancer patients: developing nursing theory. Oncol Nurs Forum 14:17–23PubMed Piper BF, Lindsey AM, Dodd MJ (1987) Fatigue mechanism in cancer patients: developing nursing theory. Oncol Nurs Forum 14:17–23PubMed
8.
Zurück zum Zitat Smets EM, Garssen B, Bonke B, De Haes JC (1995) The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 39:315–325PubMedCrossRef Smets EM, Garssen B, Bonke B, De Haes JC (1995) The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 39:315–325PubMedCrossRef
9.
Zurück zum Zitat Hagelin CL, Wengström Y, Runesdotter S, Fürst CJ (2007) The psychometric properties of the Swedish Multidimensional Fatigue Inventory MFI-20 in four different population. Acta Oncol 46:97–104PubMedCrossRef Hagelin CL, Wengström Y, Runesdotter S, Fürst CJ (2007) The psychometric properties of the Swedish Multidimensional Fatigue Inventory MFI-20 in four different population. Acta Oncol 46:97–104PubMedCrossRef
10.
Zurück zum Zitat Smets EM, Garssen B, Cull A, De Haes JC (1996) Application of the multidimensional fatigue inventory (MFI-20) in cancer patients receiving radiotherapy. Br J Cancer 73:241–245PubMedCrossRef Smets EM, Garssen B, Cull A, De Haes JC (1996) Application of the multidimensional fatigue inventory (MFI-20) in cancer patients receiving radiotherapy. Br J Cancer 73:241–245PubMedCrossRef
11.
Zurück zum Zitat Aronson NK, Cull A, Keasa S et al (1994) The European Organization for Research and Treatment of Cancer (EORTC) modular approach to quality of life assessment in oncology. Int J Ment Health 23(2):75–96 Aronson NK, Cull A, Keasa S et al (1994) The European Organization for Research and Treatment of Cancer (EORTC) modular approach to quality of life assessment in oncology. Int J Ment Health 23(2):75–96
12.
Zurück zum Zitat Zhen LC, Tian HR, Xie PZ (2000) Medical quality of survival evaluation. Junshi Yixue Kexue Press, Beijing Zhen LC, Tian HR, Xie PZ (2000) Medical quality of survival evaluation. Junshi Yixue Kexue Press, Beijing
13.
Zurück zum Zitat Nunnally JM, Bernstein IH (1994) Psychometric theory, 3rd edn. McGraw-Hill, New York Nunnally JM, Bernstein IH (1994) Psychometric theory, 3rd edn. McGraw-Hill, New York
14.
Zurück zum Zitat Schneider RA (1998) Reliability and validity of the Multidimensional Fatigue Inventory (MFI-20) and the Rhoten Fatigue Scale among rural cancer outpatients. Cancer Nurs 21(5):370–373PubMedCrossRef Schneider RA (1998) Reliability and validity of the Multidimensional Fatigue Inventory (MFI-20) and the Rhoten Fatigue Scale among rural cancer outpatients. Cancer Nurs 21(5):370–373PubMedCrossRef
15.
Zurück zum Zitat Gentile S, Delarozière JC, Favre F, Sambuc R, San Marco JL (2003) Validation of the French ‘multidimensional fatigue inventory’ (MFI 20). Eur J Cancer Care 12:58–64CrossRef Gentile S, Delarozière JC, Favre F, Sambuc R, San Marco JL (2003) Validation of the French ‘multidimensional fatigue inventory’ (MFI 20). Eur J Cancer Care 12:58–64CrossRef
16.
Zurück zum Zitat Hagelin CL, Wengström Y, Fürst CJ (2009) Patterns of fatigue related to advanced disease and radiotherapy in patients with cancer—a comparative cross-sectional study of fatigue intensity and characteristics. Support Care Cancer 17:519–526CrossRef Hagelin CL, Wengström Y, Fürst CJ (2009) Patterns of fatigue related to advanced disease and radiotherapy in patients with cancer—a comparative cross-sectional study of fatigue intensity and characteristics. Support Care Cancer 17:519–526CrossRef
17.
Zurück zum Zitat Kuhnt S, Ernst J, Singer S, Rüffer JU, Kortmann R-D, Stolzenburg J, Schwarz R (2009) Fatigue in cancer survivors—prevalence and correlates. Onkologie 32:312–317PubMedCrossRef Kuhnt S, Ernst J, Singer S, Rüffer JU, Kortmann R-D, Stolzenburg J, Schwarz R (2009) Fatigue in cancer survivors—prevalence and correlates. Onkologie 32:312–317PubMedCrossRef
18.
Zurück zum Zitat Munch TN, Strömgren AS, Pedersen L, Petersen MA, Hoermann L, Groenvold M (2006) Multidimensional measurement of fatigue in advanced cancer patients in palliative care: an application of the Multidimensional Fatigue Inventory. J Pain Symptom Manage 31(6):533–541PubMedCrossRef Munch TN, Strömgren AS, Pedersen L, Petersen MA, Hoermann L, Groenvold M (2006) Multidimensional measurement of fatigue in advanced cancer patients in palliative care: an application of the Multidimensional Fatigue Inventory. J Pain Symptom Manage 31(6):533–541PubMedCrossRef
19.
Zurück zum Zitat Lundh HC, Wengström Y, Runesdotter S, Fűrst CJ (2007) The psychometric properties of the Swedish Multidimensional Fatigue Inventory MFI-20 in four different populations. Acta Oncol 46:97–104CrossRef Lundh HC, Wengström Y, Runesdotter S, Fűrst CJ (2007) The psychometric properties of the Swedish Multidimensional Fatigue Inventory MFI-20 in four different populations. Acta Oncol 46:97–104CrossRef
Metadaten
Titel
Validation of the Chinese version of Multidimensional Fatigue Inventory-20 in Chinese patients with cancer
verfasst von
Jun Tian
Jin-Sheng Hong
Publikationsdatum
01.10.2012
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 10/2012
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-011-1357-8

Weitere Artikel der Ausgabe 10/2012

Supportive Care in Cancer 10/2012 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.